USPTO serial 79189610
BDC
Reviewed by CopyMark Law Group
Reg. 5225285Status 709
- Filing date
- Status date
- Registration date
- Jun 20, 2017
- Examiner
- FALK, JONATHAN ROBERT
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BDC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
GB
GB
GB
GB
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products, namely, pharmaceutical preparations for use in oncology, both solid and liquid tumours, metabolic disease, urology and renal disease, cardiovascular, haematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, infectious disease, both bacterial and viral, neurological and psychiatric disorders; pharmaceutical preparations for use as diagnostics and clinical imaging agents | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services, namely, scientific research, diagnosis of disease and development of future human and veterinary medical treatments in the field of oncology, both solid and liquid tumours, metabolic disease, urology and renal disease, cardiovascular, haematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, infectious disease, both bacterial and viral, neurological and psychiatric disorders, diagnostics and clinical imaging agents; industrial analysis and research services in the field of oncology, both solid and liquid tumours, metabolic disease, urology and renal disease, cardiovascular, haematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, infectious disease, both bacterial and viral, neurological and psychiatric disorders, and diagnostics and clinical imaging agents; information, consultancy and advisory services relating to design, planning and implementation of scientific and clinical research for others | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Bicycletx Limited
- Other trademarks owned by Bicycle Therapeutics Limited
- Other trademarks owned by Bicycle Therapeutics Limited
- Other trademarks owned by Bicycle Therapeutics Limited
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named BDC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 7, 2024 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Sep 12, 2024 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Sep 12, 2024 | INPC | INVALIDATION PROCESSED | — |
| Sep 6, 2024 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 5, 2024 | C71T | CANCELLED SECTION 71 | — |
| Dec 1, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 24, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jun 20, 2022 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Sep 17, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 21, 2019 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Oct 28, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 22, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 22, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 20, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 28, 2017 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 28, 2017 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 20, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 4, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 1, 2017 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 15, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 15, 2017 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 15, 2017 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 27, 2017 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Feb 24, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 24, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 24, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 3, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 2, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 2, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 2, 2016 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 12, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 12, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 9, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 9, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 8, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 5, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 5, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 4, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |